February 15, 2022 – The Tolan Group (TTG) recently placed Paul Valenti as the new CFO of The Plastic Surgery Center. “It was a privilege to work with Dr. Elkwood and the hiring team to bring on such a crucial member of the executive staff,” said Kaye Johnson, managing partner of the search firm that led the assignment. “We felt like Mr. Valenti was the perfect fit to help lead The Plastic Surgery Center in their next level of growth and expansion.” Ms. Johnson was recently named co-CEO of The Tolan Group after serving in leadership capacities for the firm over the past eight years.
Mr. Valenti served as CFO of several healthcare companies. He was previously with The Eye Health Group, a vision support organization in New Jersey and New York performing comprehensive eye care services and Total Rx, a specialty, long-term care, and retail pharmacy. He also served as CFO at Aureus Health Services, a national specialty pharmacy and health services company, and QForma, a SaaS provider to pharmaceutical companies.
The Plastic Surgery Center is the largest plastic surgery practice in New Jersey, attracting patients from across the country and around the globe. It is distinguished by the outstanding training and background of its surgeons. The Plastic Surgery Center uniquely houses The Institute for Advanced Reconstruction, their reconstructive entity, which focuses on an array of nerve surgeries and other cutting-edge reconstructive procedures to treat various debilitating conditions for patients who were previously told nothing could be done to help them.
Established in 2005, The Tolan Group provides executive search services for behavioral health, substance abuse, human services, healthcare software and services, health plans/payers, software and services vendors that support the healthcare continuum as well as life sciences and biopharma. The firm is based in St Augustine, FL, with satellite offices in Atlanta; Philadelphia; Appleton, WI; and Tampa, FL.
The Tolan Group (TTG) recently placed Mark Attarian as the new CFO of Pharmalogic Holdings Inc. Managing partners Kaye Johnson and Rachel Gauthier and senior search consultant Jennifer Chee led the assignment. “We were honored to work with Steve Chilinski, CEO of Pharmalogic, and his team on this engagement,” said Tim Russell, managing partner of The Tolan Group. “Due to Attarian’s successful track record of financial and operational success, our team believes he was the foremost candidate to help lead Pharmalogic to their next level of growth and expansion.”
Timothy J. Tolan is CEO and managing partner for The Tolan Group. He has conducted searches for CEOs, CIO’s, COO’s CFO’s, presidents, senior vice presidents, vice presidents of business development, product development and sales professionals. He has worked with large and small cap companies, as well as privately held and early stage companies. In addition to his executive search experience, Mr. Tolan has been in the healthcare technology field for over 25 years holding executive-level positions for companies both public and private.
Ms. Johnson most recently served as chief operating officer at The Tolan Group before being elevated to the co-CEO post earlier this month. Ms. Johnson leads day-to-day operations, major projects and is responsible for all search execution for the firm. She directs the project team responsible for sourcing and qualifying candidates for placement. Since joining the firm, Ms. Johnson has placed C-suite, EVPs, SVPs, VPs and countless individual contributors in sales, marketing, product management, as well as technical and clinical talent.
New Pressures on CFOs
Immediate concerns around cash flow, liquidity and the bottom line are taking precedence at many companies due to continued fallout from the pandemic. But there are high-value lessons emerging from the current health and economic crisis that chief financial officers should bear in mind, according to recruiters specializing in finding talent for finance functional roles.
The COVID-19 crisis has thrust CFOs into the spotlight as never before, they report, while the pandemic itself has also created a business environment in which CFOs are uniquely positioned to drive business value during the recovery phase, which is expected to come into 2022.
All too many companies today are desperate to get as much cash on their balance sheets as possible in order to ride out the storm of COVID-19, say recruiters. Bottom-line pressures are forcing many businesses to shift their forecasting strategies, explore new products and services — or even expand into alternative sales and delivery channels. The best CFOs are spearheading that effort.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media